Crystal structure of (E)-13-(pyrimidin-5-yl)parthenolide

The title compound, C19H22N2O3, {systematic name (1aR,4E,7aS,8E,10aS,10bR)-1a,5-dimethyl-8-[(pyrimidin-5-yl)methylidene]-2,3,6,7,7a,8,10a,10b-octahydrooxireno[2′,3′:9,10]cyclodeca[1,2-b]furan-9(1aH)-one} was obtained from the reaction of parthenolide [systematic name (1aR,7aS,10aS,10bR,E)-1a,5-dimet...

Full description

Bibliographic Details
Main Authors: Shobanbabu Bommagani, Narsimha R. Penthala, Sean Parkin, Peter A. Crooks
Format: Article
Language:English
Published: International Union of Crystallography 2015-12-01
Series:Acta Crystallographica Section E: Crystallographic Communications
Subjects:
Online Access:http://scripts.iucr.org/cgi-bin/paper?S2056989015021507
id doaj-cee554514b3b4b42828d9834b588cdfc
record_format Article
spelling doaj-cee554514b3b4b42828d9834b588cdfc2020-11-24T22:23:38ZengInternational Union of CrystallographyActa Crystallographica Section E: Crystallographic Communications2056-98902015-12-0171121536153810.1107/S2056989015021507zs2350Crystal structure of (E)-13-(pyrimidin-5-yl)parthenolideShobanbabu Bommagani0Narsimha R. Penthala1Sean Parkin2Peter A. Crooks3Dept. of Pharm. Sciences, College of Pharmacy, University of Arkansas for Medical Sciences, Little Rock, AR 72205, USADept. of Pharm. Sciences, College of Pharmacy, University of Arkansas for Medical Sciences, Little Rock, AR 72205, USADept. of Chemistry, University of Kentucky, Lexington KY 40506, USADept. of Pharm. Sciences, College of Pharmacy, University of Arkansas for Medical Sciences, Little Rock, AR 72205, USAThe title compound, C19H22N2O3, {systematic name (1aR,4E,7aS,8E,10aS,10bR)-1a,5-dimethyl-8-[(pyrimidin-5-yl)methylidene]-2,3,6,7,7a,8,10a,10b-octahydrooxireno[2′,3′:9,10]cyclodeca[1,2-b]furan-9(1aH)-one} was obtained from the reaction of parthenolide [systematic name (1aR,7aS,10aS,10bR,E)-1a,5-dimethyl-8-methylene-2,3,6,7,7a,8,10a,10b-octahydrooxireno[2′,3′:9,10]cyclodeca[1,2-b]furan-9(1aH)-one] with 5-bromopyrimidine under Heck reaction conditions, and was identified as an E isomer. The molecule possesses ten-, five- (lactone) and three-membered (epoxide) rings with a pyrimidine group as a substituent. The ten-membered ring displays an approximate chair–chair conformation, while the lactone ring shows a flattened envelope-type conformation. The dihedral angle between the pyrimidine moiety and the lactone ring system is 29.43 (7)°.http://scripts.iucr.org/cgi-bin/paper?S2056989015021507crystal structureparthenolidepyrimidineHeck product
collection DOAJ
language English
format Article
sources DOAJ
author Shobanbabu Bommagani
Narsimha R. Penthala
Sean Parkin
Peter A. Crooks
spellingShingle Shobanbabu Bommagani
Narsimha R. Penthala
Sean Parkin
Peter A. Crooks
Crystal structure of (E)-13-(pyrimidin-5-yl)parthenolide
Acta Crystallographica Section E: Crystallographic Communications
crystal structure
parthenolide
pyrimidine
Heck product
author_facet Shobanbabu Bommagani
Narsimha R. Penthala
Sean Parkin
Peter A. Crooks
author_sort Shobanbabu Bommagani
title Crystal structure of (E)-13-(pyrimidin-5-yl)parthenolide
title_short Crystal structure of (E)-13-(pyrimidin-5-yl)parthenolide
title_full Crystal structure of (E)-13-(pyrimidin-5-yl)parthenolide
title_fullStr Crystal structure of (E)-13-(pyrimidin-5-yl)parthenolide
title_full_unstemmed Crystal structure of (E)-13-(pyrimidin-5-yl)parthenolide
title_sort crystal structure of (e)-13-(pyrimidin-5-yl)parthenolide
publisher International Union of Crystallography
series Acta Crystallographica Section E: Crystallographic Communications
issn 2056-9890
publishDate 2015-12-01
description The title compound, C19H22N2O3, {systematic name (1aR,4E,7aS,8E,10aS,10bR)-1a,5-dimethyl-8-[(pyrimidin-5-yl)methylidene]-2,3,6,7,7a,8,10a,10b-octahydrooxireno[2′,3′:9,10]cyclodeca[1,2-b]furan-9(1aH)-one} was obtained from the reaction of parthenolide [systematic name (1aR,7aS,10aS,10bR,E)-1a,5-dimethyl-8-methylene-2,3,6,7,7a,8,10a,10b-octahydrooxireno[2′,3′:9,10]cyclodeca[1,2-b]furan-9(1aH)-one] with 5-bromopyrimidine under Heck reaction conditions, and was identified as an E isomer. The molecule possesses ten-, five- (lactone) and three-membered (epoxide) rings with a pyrimidine group as a substituent. The ten-membered ring displays an approximate chair–chair conformation, while the lactone ring shows a flattened envelope-type conformation. The dihedral angle between the pyrimidine moiety and the lactone ring system is 29.43 (7)°.
topic crystal structure
parthenolide
pyrimidine
Heck product
url http://scripts.iucr.org/cgi-bin/paper?S2056989015021507
work_keys_str_mv AT shobanbabubommagani crystalstructureofe13pyrimidin5ylparthenolide
AT narsimharpenthala crystalstructureofe13pyrimidin5ylparthenolide
AT seanparkin crystalstructureofe13pyrimidin5ylparthenolide
AT peteracrooks crystalstructureofe13pyrimidin5ylparthenolide
_version_ 1725764600197021696